Since we listed Psyence on the Canadian Securities Exchange (CSE) in January 2021, we have commenced cultivation, started research and development, and recruited extraordinary medical and scientific talent to collaborate in finding psychedelic-assisted solutions to the current mental health crisis. The enduring work of Psyence is to develop and provide innovative, safe and responsible psychedelic and nature-based solutions for mental health and mental wellness that heal, open consciousness, and nurture community.
This is a unique time in the history of medicine and pharmaceutical drug development and that is why we launched “The Diary of a Psychedelic Exec.”
If you are an investor or interested in psychedelic healing and what Psyence is up to, then please join us each week as we share the work of building a sustainable business that delivers shareholder value.
– Jody Aufrichtig, Co-founder and Executive Chairman, Psyence
We value your feedback – email@example.com